Avicanna
Joining the Company in 2021 as Senior Vice President of Finance, Phillip took over as Interim Chief Financial Officer in May 2022. He gained his experience at MNP LLP in the public company assurance group, where worked with new and young companies, managing, and advising them through go-public transactions and f financial reporting requirements. While at MNP, Phillip was audit lead for Avicanna from 2018-2020. He is applying this prior knowledge to ensuring accuracy and reliability of Avicanna’s financials and sound financial management.
This person is not in any teams
This person is not in any offices
Avicanna
Avicanna is an innovative biopharmaceutical company in the medical cannabis space. We are dedicated to scientific & evidence-based delivery of cannabinoid-based products.